Thrombosis with thrombocytopenia syndrome following adenovirus vector-based vaccines to prevent COVID-19: Epidemiology and clinical presentation in Spain

Thrombosis with thrombocytopenia syndrome following adenovirus vector-based vaccines to prevent COVID-19: Epidemiology and clinical presentation in Spain

Background: We describe the epidemiological and clinical characteristics of thrombosis with thrombocytopenia syndrome (TTS) cases reported in Spain. Methods: We included all cases of venous or arterial thrombosis with thrombocytopenia following administration of adenoviral vector vaccines (AstraZene...

Full description

Saved in:
Bibliographic Details
Main Authors: D. García-Azorín, E. Lázaro, D. Ezpeleta, R. Lecumberri, R. de la Cámara, M. Castellanos, C. Iñiguez Martínez, L. Quiroga-González, G. Elizondo Rivas, A. Sancho-López, P. Rayón Iglesias, E. Segovia, C. Mejías, D. Montero Corominas
Format: Article
Language:English
Published: Elsevier España 2024-11-01
Series:Neurología (English Edition)
Subjects:
MeSH Terms
COVID-19
Efectos adversos de medicamentos y reacciones adversas
Vacunas
Embolia y trombosis
Trastornos plaquetarios
Online Access:http://www.sciencedirect.com/science/article/pii/S2173580824000828
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2173580824000828

Similar Items